ASX-listed medical cannabis player MGC Pharmaceuticals is set to achieve a major commercial milestone as it edges closer to getting the final green light for its European medical marijuana facility. The company expects to receive official approval for the Slovenian facility this month after being granted an interim licence in January, bringing an 18-month approvals process near to completion.
07/03/2018 - 05:48
MGC Pharma on brink of European medical cannabis approval
By Matt Birney
07/03/2018 - 05:48
Related Data & Insights
-
-
Rank Company Revenue th Argent BioPharma $1.7m 201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
01 Dec 2023
Board Moves December 1, 2023
28 Jul 2023
Board Moves July 28, 2023
30 Jun 2023
MGC Pharma sacks senior staffer
07 Jun 2023
Board Moves May 31 to June 2, 2023
01 Mar 2023
Board Moves March 1, 2023
03 Jan 2023
Board Moves January 3, 2023
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX